Johnson Competitors

JNJ Stock  USD 162.12  0.74  0.46%   
Johnson Johnson competes with Vaxxinity, YS Biopharma, 23Andme Holding, Agilent Technologies, and DermTech; as well as few others. The company runs under Pharmaceuticals sector within Health Care industry. Analyzing Johnson Johnson competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Johnson Johnson to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Johnson Johnson Correlation with its peers.
For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Johnson Johnson competition on your existing holdings.
  
Return on Investment is expected to hike to 19.41 this year, although the value of Return on Average Assets will most likely fall to 0.17. At this time, Johnson Johnson's Revenue to Assets are relatively stable as compared to the past year. Net Current Assets as percentage of Total Assets is expected to hike to 4.42 this year, although the value of Asset Turnover will most likely fall to 0.46.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Johnson Johnson's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Johnson Johnson in the context of predictive analytics.
Hype
Prediction
LowEstimatedHigh
161.37162.08162.79
Details
Intrinsic
Valuation
LowRealHigh
150.80151.51178.33
Details
22 Analysts
Consensus
LowTargetHigh
153.30168.46186.99
Details
Earnings
Estimates (0)
LowProjected EPSHigh
2.442.632.77
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Johnson Johnson. Your research has to be compared to or analyzed against Johnson Johnson's peers to derive any actionable benefits. When done correctly, Johnson Johnson's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Johnson Johnson.

Johnson Johnson Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Johnson Johnson and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Johnson and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Johnson Johnson does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
KAME
VALNME
KAVALN
DMTKME
VALNDMTK
KADMTK
  
High negative correlations   
EQVALN
KAEQ
EQME
EQYS
KAVANI
EQDMTK

Risk-Adjusted Indicators

There is a big difference between Johnson Stock performing well and Johnson Johnson Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Johnson Johnson's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
VAXX  4.00  0.08  0.00  0.36  4.73 
 8.45 
 45.91 
YS  4.77 (0.48) 0.00 (0.10) 0.00 
 9.80 
 31.19 
ME  4.85 (1.06) 0.00 (0.20) 0.00 
 10.47 
 34.64 
A  1.09 (0.06) 0.01  0.11  1.34 
 2.31 
 9.31 
DMTK  4.51 (0.85) 0.00 (0.36) 0.00 
 9.21 
 27.44 
VALN  2.38 (0.89) 0.00 (0.60) 0.00 
 5.47 
 18.59 
VANI  8.97  4.53  0.67 (1.25) 3.66 
 5.68 
 257.46 
EQ  6.30  2.64  0.41  1.56  4.54 
 24.49 
 70.42 
KA  4.47 (1.39) 0.00 (1.20) 0.00 
 8.54 
 74.29 
DMAC  2.87 (0.12) 0.04  0.11  3.37 
 6.38 
 20.43 

Cross Equities Net Income Analysis

Compare Johnson Johnson and related stocks such as Vaxxinity, YS Biopharma, and 23Andme Holding Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
VAXX(14.2 M)(14.2 M)(14.2 M)(14.2 M)(14.2 M)(14.2 M)(14.2 M)(14.2 M)(14.2 M)(14.2 M)(40 M)(137.2 M)(75.2 M)(67.7 M)(73 M)
YS(208.4 M)(208.4 M)(208.4 M)(208.4 M)(208.4 M)(208.4 M)(208.4 M)(208.4 M)(208.4 M)(208.4 M)(208.4 M)(236.7 M)(283.5 M)(255.1 M)(275.3 M)
ME(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(250.9 M)(183.6 M)(217.5 M)(311.7 M)(280.5 M)(302.6 M)
A734 M734 M734 M549 M401 M462 M684 M316 M1.1 B719 M1.2 B1.3 B1.2 B1.4 B1.2 B
DMTK(60.0)(60.0)(60.0)(60.0)(60.0)(60.0)(60.0)(10 M)(10 M)(20.1 M)(36.5 M)(78.3 M)(116.7 M)(100.9 M)(103.5 M)
VALN(1.7 M)(1.7 M)(1.7 M)(1.7 M)(1.7 M)(1.7 M)(1.7 M)(1.7 M)(1.7 M)(1.7 M)(64.4 M)(73.4 M)(143.3 M)(129 M)(132.3 M)
VANI(23 M)(23 M)(23 M)(23 M)(35.2 M)(20 M)(33.2 M)(28.5 M)(35.1 M)(33.6 M)(14.9 M)(12.8 M)(13.9 M)(16 M)(17.2 M)
EQ(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(25.6 M)(29.8 M)(39.1 M)(62.4 M)(56.2 M)(57.7 M)
KA(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.8 M)(25 M)(37.2 M)(59.4 M)(61.8 M)(31.2 M)(57.5 M)(11.8 M)(63.4 M)(57.1 M)(61.6 M)
DMAC(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(2.2 M)(4.3 M)(5.7 M)(10.6 M)(12.3 M)(13.6 M)(13.7 M)(12.3 M)(13.3 M)

Johnson Johnson and related stocks such as Vaxxinity, YS Biopharma, and 23Andme Holding Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Johnson Johnson financial statement analysis. It represents the amount of money remaining after all of Johnson Johnson operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Johnson Johnson Competitive Analysis

The better you understand Johnson Johnson competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Johnson Johnson's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Johnson Johnson's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
JNJVAXXYSMEADMTKVALNVANIEQKA
 0.46 
 162.12 
Johnson
 8.14 
 0.79 
Vaxxinity
 13.16 
 0.43 
YS Biopharma
 5.26 
 0.54 
23Andme
 1.24 
 139.06 
Agilent
 32.03 
 0.87 
DermTech
 0.42 
 7.07 
Valneva
 26.78 
 3.09 
Vivani
 0.40 
 2.50 
Equillium
 8.54 
 0.89 
Kineta
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Johnson Johnson Competition Performance Charts

Five steps to successful analysis of Johnson Johnson Competition

Johnson Johnson's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Johnson Johnson in relation to its competition. Johnson Johnson's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Johnson Johnson in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Johnson Johnson's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Johnson Johnson, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Johnson Johnson position

In addition to having Johnson Johnson in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Chemicals Thematic Idea Now

Chemicals
Chemicals Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:

Complementary Tools for Johnson Stock analysis

When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Johnson Johnson's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.106
Dividend Share
4.7
Earnings Share
5.2
Revenue Per Share
33.613
Quarterly Revenue Growth
0.073
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.